Kimberley Lee

Dr. Kimberley Lee is an Assistant Professor at the Perelman School of Medicine, University of Pennsylvania, where she serves as a Medical Oncologist at the Abramson Cancer Center, Penn Presbyterian Medical Center. She completed her medical education at Johns Hopkins University School of Medicine and residency at Johns Hopkins Hospital. Dr. Lee is actively involved in patient care, accepting new patients at Penn Medicine.

Dr. Lee's research focuses on breast cancer treatment with particular emphasis on endocrine therapy, ovarian function suppression, and addressing health disparities in cancer care. Her work examines treatment decision-making processes, barriers to therapy adherence (especially among Black breast cancer survivors), and the implementation of digital health solutions for cancer genetic testing. She investigates the hidden costs of cancer treatments and patient-provider communication around complex therapeutic options.

Analysis of Dr. Lee's recent publications (2024-2025) reveals a strong focus on health equity in breast cancer care, with multiple studies examining racial disparities in treatment adherence and outcomes. Her research combines qualitative and quantitative methodologies, often employing mixed-methods approaches to understand complex patient experiences. Dr. Lee is particularly active in digital health innovation through the eREACH Study, which explores alternative delivery models for cancer genetic testing.

Dr. Lee collaborates extensively with researchers across multiple institutions, as evidenced by her co-authorship on numerous publications with investigators from various cancer centers and universities. Her work appears in respected oncology journals including Breast Cancer Research and Treatment, Clinical Breast Cancer, and Journal of Cancer Survivorship.

As a practicing oncologist and active researcher, Dr. Lee contributes to both clinical care and scientific advancement in breast cancer treatment, with a distinctive focus on improving equity and accessibility in cancer care delivery.